Global Cytokine Market Set for Significant Growth, Projected to Reach $ 130.5 Billion by 2028
October 27, 2023 10:28 ET
|
Research and Markets
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The "Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's...
North American Leads in the Cancer Biologics Global Market 2023 With the Middle East Expected to be the Fastest Growing Region
September 25, 2023 08:48 ET
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Cancer biologics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global cancer biologics market is expected...
Global Psychobiotics Market Analysis and Opportunity Forecast to 2028: Escalating Concerns About Mental Health Issues, Accentuated by the COVID-19 Pandemic
August 22, 2023 07:08 ET
|
Research and Markets
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Global Psychobiotics Market Assessment 2018-2028 report has been added to ResearchAndMarkets.com's offering. The Global Psychobiotics market is...
GMP Cell Therapy Consumables Market Report – Reach $59.98 Billion, Globally by 2028 with 27.5% CAGR During 2022-2028 | The Insight Partners
June 19, 2023 08:00 ET
|
The Insight Partners
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "GMP Cell Therapy Consumables Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product,...
Global Immuno-Oncology Thematic Intelligence Report 2023: Focus on Trends in Bispecific Antibodies, Cancer Vaccines, Cell Therapies, Checkpoint Modulators, Cytokines, & Oncolytic Viruses
June 13, 2023 04:48 ET
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Thematic Intelligence" report has been added to ResearchAndMarkets.com's offering.This report includes coverage of immuno-oncology...
TILT Biotherapeutics Announces First Patient Dosed in Phase I Solid Tumors Trial Assessing Oncolytic Adenovirus TILT-123 in Combination with Checkpoint Inhibitor
May 15, 2023 02:00 ET
|
TILT Biotherapeutics Oy
HELSINKI, Finland, May 15, 2023 (GLOBE NEWSWIRE) -- TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, today announced that the first patient has been...
Global Natural Killer (NK) Cell Therapeutics Market Research Report 2023: 10 Recent Partnerships & Funding Deals, Clinical Trials Insight for 200 Therapies, Proprietary Technologies by Company
March 31, 2023 04:08 ET
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "Global Natural Killer (NK) Cell Therapeutics Market Trends, Companies & Clinical Trials Insight 2023" report has been added to ...
Global GMP Protein (E. coli) Contract Manufacturing Market to Surpass US$ 1,439.1 Million by 2030, Says Coherent Market Insights (CMI)
January 05, 2023 09:30 ET
|
CMI
Burlingame, Jan. 05, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global GMP protein (E. coli) contract manufacturing market is estimated to be valued at US$ 685.8 million in...
Immuno-oncology Global Market Report 2022: Approval of Novel Therapies Boosts Sector Growth
November 30, 2022 05:48 ET
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User...
Provectus Biopharmaceuticals Expands Research Collaboration with The Rockefeller University to Investigate Clinical-Stage Immuno-Dermatology Agent PH-10 for Skin Inflammation
October 25, 2022 06:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has expanded its sponsored research program with James G. Krueger, MD, PhD, Co-director,...